Terms: = Lymphoma AND MNX1, HB9, 3110, ENSG00000130675, P50219, HLXB9 AND Treatment
4 results:
1. Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.
Anastasopoulou S; Nielsen RL; Als-Nielsen B; Banerjee J; Eriksson MA; Helenius M; Heyman MM; Johannsdottir IM; Jonsson OG; MacGregor S; Mateos MK; Mayoh C; Mikkel S; Myrberg IH; Niinimäki R; Schmiegelow K; Taskinen M; Vaitkeviciene G; Warnqvist A; Wolthers B; Harila-Saari A; Ranta S
Haematologica; 2022 Oct; 107(10):2318-2328. PubMed ID: 35354251
[TBL] [Abstract] [Full Text] [Related]
2. Sedation practices in pediatric patients with acute lymphoblastic leukemia.
Nugent BD; Davis PJ; Noll RB; Tersak JM
Pediatr Blood Cancer; 2020 Feb; 67(2):e28037. PubMed ID: 31625677
[TBL] [Abstract] [Full Text] [Related]
3. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].
Wang X; Xia B; Wang CY; Li MZ; Xu W; Yuan T; Tian C; Zhao HF; Yang HL; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):117-124. PubMed ID: 30831626
[No Abstract] [Full Text] [Related]
4. hlxb9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3.
Nagel S; Scherr M; Quentmeier H; Kaufmann M; Zaborski M; Drexler HG; MacLeod RA
Leukemia; 2005 May; 19(5):841-6. PubMed ID: 15772702
[TBL] [Abstract] [Full Text] [Related]
